Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H.

作者: Zipfel Pf , Meri S , Solomon A , Jokiranta Ts , Pangburn Mk

DOI:

关键词:

摘要: A unique monoclonal Ig lambda light chain dimer (protein LOI) was isolated from the serum and urine of a patient with hypocomplementemic membranoproliferative glomerulonephritis. In vitro efficiently activated alternative pathway complement (AP). When added to normal human serum, LOI temporarily enhanced AP hemolytic activity, but during prolonged incubation activity depleted. Protein found bind factor H, main regulator molecule AP. By binding short consensus repeat domain 3 blocked one three interaction sites between H C3b thus inhibited induced an uncontrolled activation Structural analysis showed that belonged Vlambda3a subgroup chains. The variable (V) region most closely related predicted product Vlambda3 germline gene Iglv3s2, although it contained several residues in tertiary homology model structure form unusual ring charged around hydrophobic groove putative Ag site. This site fitted considerably well molecular containing reciprocal amino acids area. Apparently, functional blocking by Ab fragment-like had initiated development severe Thus, represents first described pathogenic miniautoantibody disease.

参考文章(44)
K. Høgåsen, J. H. Jansen, T. E. Mollnes, Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease). American Journal of Pathology. ,vol. 143, pp. 1356- 1365 ,(1993)
Elvin A. Kabat, Sequences of proteins of immunological interest National Institutes of Health. ,(1991)
R M Kaufman, D L Gordon, T K Blackmore, D M Lublin, J Kwong, Identification of complement regulatory domains in human factor H. Journal of Immunology. ,vol. 155, pp. 348- 356 ,(1995)
M. Sun, L. Li, Q.S. Gao, S. Paul, Antigen Recognition by an Antibody Light Chain Journal of Biological Chemistry. ,vol. 269, pp. 734- 738 ,(1994) , 10.1016/S0021-9258(17)42411-2
R A Thompson, M H Winterborn, Hypocomplementaemia due to a genetic deficiency of beta 1H globulin. Clinical and Experimental Immunology. ,vol. 46, pp. 110- 119 ,(1981)
S Kühn, C Skerka, P F Zipfel, Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. Journal of Immunology. ,vol. 155, pp. 5663- 5670 ,(1995)
K. Frank Austen, Douglas T. Fearon, Mohamed R. Daha, C3 Nephritic Factor (C3NeF): Stabilization of Fluid Phase and Cell-Bound Alternative Pathway Convertase Journal of Immunology. ,vol. 116, pp. 1- 7 ,(1976)
Otto Götze, Hans J. Müller-Eberhard, THE C3-ACTIVATOR SYSTEM: AN ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION Journal of Experimental Medicine. ,vol. 134, pp. 90- 108 ,(1971) , 10.1084/JEM.134.3.90
C Murphy, D T Weiss, A Solomon, M Eulitz, Serologic and chemical differentiation of human lambda III light chain variable regions. Journal of Immunology. ,vol. 146, pp. 3091- 3096 ,(1991)
Paul Warwicker, Timothy H.J. Goodship, Rosemary L. Donne, Yves Pirson, Anthony Nicholls, Roy M. Ward, Peter Turnpenny, Judith A. Goodship, Genetic studies into inherited and sporadic hemolytic uremic syndrome Kidney International. ,vol. 53, pp. 836- 844 ,(1998) , 10.1111/J.1523-1755.1998.00824.X